Last Posted: Sep 13, 2019
- Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.
Cresci Sharon et al. Circulation. Genomic and precision medicine 2019 Sep HCG0000000000000058 - A protocol integrating remote patient monitoring patient reported outcomes and cardiovascular biomarkers
C Shufelt et al, NPJ Digital Medicine, September 3, 2019 - Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease
B Ference et al JAMA, September 2, 2019 - Association of Multifaceted Mobile Technology–Enabled Primary Care Intervention With Cardiovascular Disease Risk Management in Rural Indonesia
A Patel et al, JAMA Cardiology, August 2019 - Pharmacogenetics of statins treatment: Efficacy and safety.
Guan Zi-Wan et al. Journal of clinical pharmacy and therapeutics 2019 Aug - Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals.
Yano Yuichiro et al. JAMA cardiology 2019 Aug - Use of polygenic risk scores and other molecular markers to enhance cardiovascular risk prediction: prospective cohort study and modelling analysis
L Sun et al, BioRXIV, August 2019 - Prevalence and clinical importance of titin truncating variants in adults without known congestive heart failure
JP Pirruccello et al, MedRXIV, August 2019 - Congenital Heart Disease: Prenatal Diagnosis and Genetic Associations.
Hopkins Maeve K et al. Obstetrical & gynecological survey 2019 Aug 74(8) 497-503 - Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis.
Akioyamen Leo E et al. Angiology 2019 Sep 70(8) 726-736
.png)
No hay comentarios:
Publicar un comentario